Zafgen Announces Additional Weight Loss and Cardiometabolic Data from Phase 1b Studies of Beloranib in Obesity at Obesity 2012, the 30th Annual Scientific Meeting of The Obesity Society
9/24/2012 10:34:26 AM
More...
|
The Obesity Society Release: Obesity Groups See Evidence FDA Decisions Will Discourage Obesity Research
6/15/2011 6:27:51 AM
More...
|